Biomedical Engineering Science and Technology Division, Institute of Clinical Physiology, National Research Council, Lecce, Italy.
Invest Radiol. 2010 Nov;45(11):715-24. doi: 10.1097/RLI.0b013e3181e6f42f.
OBJECTIVES: To experimentally investigate the acoustical behavior of silica nanoparticles within conventional diagnostic ultrasound fields and to determine a suitable configuration, in terms of particle size and concentration, for their employment as targetable contrast agents. We also assessed the effectiveness of a novel method for automatic detection of targeted silica nanoparticles for future tissue typing applications. MATERIALS AND METHODS: Silica nanospheres of variable size (160, 330, and 660 nm in diameter) and concentration (10¹⁰-10¹³ part/mL) were dispersed in different custom-designed agarose-based gel samples and imaged at 7.5 MHz with a conventional echograph linked to a research platform for radiofrequency signal acquisition. Off-line analysis included evaluation of backscattered ultrasound amplitude, image brightness, and nanoparticle automatic detection through radiofrequency signal processing. RESULTS: Amplitude of nanoparticle-backscattered signals linearly increased with particle number concentration, but image brightness did not show the same trend, because the logarithmic compression caused the reaching of a "plateau" where brightness remained almost constant for further increments in particle concentration. On the other hand, both backscatter amplitude and image brightness showed significant increments when particle diameter was increased. Taking into account particle size constraints for tumor targeting (pore size of tumor endothelium and trapping effects because of reticulo-endothelial system limit the dimension of effectively employable particles to less than 380 nm), a suitable compromise is represented by the employment of 330-nm silica nanospheres at a concentration of about 1 to 2 x 10¹¹ part/mL. These particles, in fact, showed the best combination of number concentration and diameter value to obtain an effective enhancement on conventional echographic images. Furthermore, also the sensitivity of the developed method for automatic nanoparticle detection had a maximum (72.8%) with 330-nm particles, whereas it was lower with both bigger and smaller particles (being equal to 64.1% and 17.5%, respectively). CONCLUSIONS: Silica nanoparticles at a diameter of about 330 nm are very promising contrast agents for ultrasound imaging and specific tumor targeting at conventional diagnostic frequencies, being in particular automatically detectable with high sensitivity already at low doses. Future studies will be carried out to assess the acoustic behavior of nanoparticles with different geometries/sizes and to improve sensitivity of the automatic detection algorithm.
目的:实验研究了常规诊断超声场中二氧化硅纳米粒子的声学行为,并确定了合适的粒径和浓度配置,以便将其用作靶向对比剂。我们还评估了一种用于自动检测靶向二氧化硅纳米粒子的新方法的有效性,以便未来用于组织分型应用。
材料和方法:不同尺寸(直径 160、330 和 660nm)和浓度(10¹⁰-10¹³ 个/mL)的二氧化硅纳米球分散在不同定制设计的琼脂糖凝胶样本中,并在 7.5MHz 下用常规超声仪进行成像,该超声仪与用于射频信号采集的研究平台相连。离线分析包括通过射频信号处理评估背向散射超声幅度、图像亮度和纳米颗粒自动检测。
结果:纳米颗粒背向散射信号的幅度与颗粒数浓度呈线性增加,但图像亮度没有呈现出相同的趋势,因为对数压缩导致达到“平台”,其中亮度对于颗粒浓度的进一步增加几乎保持不变。另一方面,当粒径增加时,背散射幅度和图像亮度都显著增加。考虑到肿瘤靶向的颗粒尺寸限制(肿瘤内皮的孔隙大小和网状内皮系统的捕获效应限制了有效可利用颗粒的尺寸小于 380nm),330nm 二氧化硅纳米球的合适折衷方案是在约 1 到 2×10¹¹ 个/mL 的浓度下使用。实际上,这些颗粒表现出最佳的数量浓度和直径值组合,可在常规超声图像上获得有效增强。此外,所开发的自动纳米颗粒检测方法的灵敏度也达到了最大值(72.8%),使用 330nm 颗粒,而使用较大和较小的颗粒时灵敏度较低(分别为 64.1%和 17.5%)。
结论:直径约为 330nm 的二氧化硅纳米颗粒是很有前途的超声成像对比剂,可在常规诊断频率下进行特定的肿瘤靶向,特别是在低剂量下即可自动检测到具有高灵敏度。未来的研究将评估不同形状/尺寸的纳米颗粒的声学行为,并改进自动检测算法的灵敏度。
Chem Commun (Camb). 2009-7-29
Langmuir. 2005-9-13
Langmuir. 2007-3-13
J Colloid Interface Sci. 2006-12-1
Ultrason Sonochem. 2010-5-12
Chem Commun (Camb). 2010-11-16
Chem Commun (Camb). 2006-3-28
Med Rev (2021). 2022-10-19
ACS Biomater Sci Eng. 2022-11-14
Blood Adv. 2020-6-23
Bioeng Transl Med. 2018-10-21
Contrast Media Mol Imaging. 2018-2-7
Nanomaterials (Basel). 2016-4-11